Ivana Vanĕčková, PhD, is currently a research professor and the Head of the Department of Experimental Hypertension at the Institute of Physiology, Prague, Czech Republic. Dr. Vanĕčková graduated from Charles University in 1987. She pursued her postgraduate studies at the Institute of Physiology, Czech Academy of Sciences, where she obtained her Ph.D. Degree. Dr. Vaněčková became a postdoctoral fellow at the renal physiology laboratory at the Institute of Physiology, Prague. In 2001 she became assistant research professor at the Department of Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, where she was Head of the Department for Experimental Hypertension. As a Senior Investigator Dr. Vaněčková continued her work at the Institute of Physiology AS CR, in the Department of Experimental Hypertension where she became a research professor. She is working in endothelin research for almost 20 years with a special focus on the relationships of the renin-angiotensin and endothelin systems to blood pressure regulation and the role of endothelin receptor blockade in chronic kidney disease. Her current research is focused on gliflozin´s effects in hypertension, chronic kidney and heart disease. She is a member of the International Advisory Board of the International Conferences on Endothelin and was co-chair of the Fifteenth International Conference (ET-15), held in Prague in the Czech Republic in 2017.